A prospective safety and feasibility study of a novel device for preterm birth delay and prevention - 11/06/24
Doi : 10.1016/j.ajog.2024.05.013
Doron Kabiri, MD, MPH
Department of Obstetrics and Gynecology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel
Vincenzo Berghella, MD
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA
Hagai Amsalem, MD
Department of Obstetrics and Gynecology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel
Salem Kees, MD
Keren Ofir, MD, David Shashar, MD
Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat Gan, Israel
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Tuesday 11 June 2024
Video |
(28.07 Mo)
Plan
| D.S. is the co-founder and CEO of PregnanTech Ltd. D.K., V.B., H.H.A., and S.K. report no conflict of interest. |
|
| The study was funded by PregnanTech Ltd, Misgav, Israel. The study received a grant from the Israeli Innovation Authority (#75444, 12.2021). |
|
| Ethical approval was obtained from the Israel Ministry of Health (MOH-202121000); Hadassah Medical Center (0273-21-HMO); Sheba Tel-HaShomer Medical Centre (8245-21-SMC); Kaplan Medical Center (0116-22-KMC). |
© 2024
Elsevier Inc. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?